| Literature DB >> 32947814 |
Dongxiang Chen1,2, Han Zhao1, Jun Zhao1, Zhenci Xu3, Shaohua Wu4.
Abstract
The high-precision mapping of urban health risk is a difficult problem due to the high heterogeneity of the urban environment. In this paper, the spatial distribution characteristics of the Polycyclic Aromatic Hydrocarbon (PAH) content in the urban soil of Shenzhen City were analyzed through a field investigation. We propose an approach for improving the accuracy and spatial resolution of PAH carcinogenic risk assessment by integrating the pollutant distribution and Location Based Service (LBS) data. The results showed that the concentration of PAHs in the high-density urban area was 271.67 ng g-1, which was 27.2% higher than that in the green area. Although the average carcinogenic risk of PAHs in the surface soil of Shenzhen city was less than 10-6, the maximum carcinogenic risk at some sample sites exceeded 10-6, which indicates a potential health risk. The LBS data were effective for high-precision mapping of the population distribution. According to the combination relationship between the risk threshold of pollutants and the population density, four types of risk zones were proposed. Among them, 6.9% of the areas had a high-risk and high population density and 15.8% of the areas were high-risk with a low population density. These two kinds of zones were the critical areas for controlling risk. The fine-scale risk mapping approach for determining the carcinogenic risk of soil PAHs integrating pollutant distribution and location based service data was demonstrated to be a useful tool for explicit spatial risk management. This tool could provide spatial insights and decision support for urban health-risk management and pollution prevention.Entities:
Keywords: PAHs; carcinogenic risk; risk assessment; spatial analysis
Mesh:
Substances:
Year: 2020 PMID: 32947814 PMCID: PMC7559718 DOI: 10.3390/ijerph17186735
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Research area and sampling sites.
Toxicity equivalent coefficient of carcinogenic Polycyclic Aromatic Hydrocarbons (PAHs).
| PAH | BaA | Chr | BbF | BkF | BaP | InP | DBA |
|---|---|---|---|---|---|---|---|
| TEF value | 0.1 | 0.01 | 0.1 | 0.1 | 1 | 0.1 | 1 |
Parameters used in the incremental lifetime carcinogenic risk assessment.
| Parameters | Unit | Value |
|---|---|---|
| average bodyweight (ABW) | kg | 58.55 |
| exposure frequency (EF) | day year−1 | 365 |
| Exposure duration(ED) | year | 24 |
| daily inhalation rate (IR inhalation) | m3 day−1 | 13.04 |
| daily ingestion rate(IR ingestion) | mg day−1 | 100 |
| dermal surface area(SA) | cm2 day−1 | 5700 |
| soil adhesion factor(AF) | mg cm−2 | 0.07 |
| dermal absorption coefficient(ABS) | 0.13 | |
| life expectancy(AT) | day | 80 × 365 |
| production factor of soil dust(PEF) | m3 kg−1 | 1.36 × 109 |
| carcinogenic slope factor of ingestion(CSF ingestion) | (mg kg−1 day−1)−1 | 7.3 |
| carcinogenic slope factor inhalation(CSF inhalation) | (mg kg−1 day−1)−1 | 3.85 |
| carcinogenic slope factor dermal exposures (CSF dermal) | (mg kg−1 day−1)−1 | 25 |
Risk zoning matrix combining risk threshold and population density.
| Order | Risk Threshold | Population Density | Risk Management Zones |
|---|---|---|---|
| 1 | >10−6 | >200 | High risk with high pop.Dens |
| 2 | >10−6 | <200 | High risk with low pop.Dens |
| 3 | <10−6 | >200 | low risk with high pop.Dens |
| 4 | <10−6 | <200 | low risk with low pop.Dens |
Notes: pop.Dens denotes population density.
The Statistical characteristics of PAHs.
| High-Density Urban (ng g−1) | Green Area (ng g−1) | |||||||
|---|---|---|---|---|---|---|---|---|
| PAHs | Min | Max | Mean | SD | Min | Max | Mean | SD |
| Nap | 11.16 | 57.29 | 24.07 | 9.78 | 6.37 | 35.62 | 18.82 | 7.80 |
| Acy | 0.69 | 35.17 | 5.96 | 6.50 | 0.89 | 7.78 | 3.81 | 2.45 |
| Ace | ND | 7.70 | 1.68 | 1.37 | 0.50 | 3.71 | 1.36 | 0.95 |
| Fl | 1.92 | 17.97 | 6.86 | 3.06 | 2.78 | 9.79 | 5.40 | 2.06 |
| Phe | 13.64 | 184.79 | 47.25 | 31.20 | 12.78 | 75.32 | 36.43 | 17.30 |
| Ant | 1.28 | 27.13 | 6.39 | 5.60 | 1.20 | 8.68 | 4.41 | 2.65 |
| Flu | 10.79 | 355.82 | 65.09 | 68.33 | 9.59 | 82.19 | 38.70 | 22.75 |
| Pyr | 8.69 | 345.27 | 54.45 | 59.76 | 7.88 | 81.00 | 34.85 | 21.30 |
| BaA | 3.30 | 217.21 | 33.99 | 37.40 | 3.96 | 63.58 | 24.35 | 17.29 |
| Chr | 3.30 | 217.78 | 54.28 | 49.25 | 2.24 | 97.77 | 40.23 | 28.01 |
| BbF | 5.91 | 336.82 | 76.12 | 73.35 | 5.68 | 184.93 | 60.56 | 49.17 |
| BkF | 1.28 | 85.50 | 20.17 | 19.42 | 1.21 | 38.94 | 14.83 | 10.60 |
| BaP | 2.45 | 171.87 | 34.22 | 33.58 | ND | 94.62 | 28.97 | 24.28 |
| InP | 3.47 | 210.55 | 43.58 | 41.48 | 3.11 | 119.95 | 36.67 | 31.64 |
| DBA | 0.25 | 35.23 | 9.30 | 8.22 | ND | 25.36 | 7.84 | 6.92 |
| BP | 3.25 | 169.35 | 42.90 | 37.06 | 1.22 | 102.71 | 39.04 | 31.74 |
| ∑PAHs | 92.84 | 2309.88 | 526.32 | 457.12 | 73.47 | 985.05 | 396.27 | 262.44 |
| ∑PAHscarc | 24.45 | 1274.96 | 271.67 | 255.35 | 24.70 | 616.27 | 213.45 | 164.43 |
Notes: SD denotes standard deviation; ND denotes not detected (below the detection limit).
Figure 2Spatial distribution of carcinogenic PAH concentrations (benz[a]anthracene, BaA (a); chrysene, Chr (b); benzo[b]fluoranthene, BbF (c); benzo[k]fluoranthene, BkF (d); benzo[a]pyrene, BaP (e); indeno[1,2,3-cd]pyrene, InP (f); dibenz[a,h]anthracene, DBA (g) and total carcinogenic PAHs (h)).
Incremental lifetime cancer risk (ILCRs) and carcinogenic risk (CR) in different exposure pathways for adults.
| Exposure Pathway | Min | Max | Mean |
|---|---|---|---|
| ILCRdermal | 1.4 × 10−8 | 1.78 × 10−6 | 3.57 × 10−7 |
| ILCRingestion | 7.9 × 10−9 | 1.1 × 10−6 | 2.01 × 10−7 |
| ILCRinhalation | 4 × 10−13 | 5.08 × 10−11 | 1.02 × 10−11 |
| Total exposure (CR) | 2.19 × 10−8 | 2.79 × 10−6 | 5.58 × 10−7 |
Figure 3Maps of Location Based Service (LBS) and PAH risk distribution (a) Population density obtained from LBS, (b) Carcinogenic risk of PAHs and (c) Health risk density (HRD).
Figure 4Spatially explicit management zones integrating carcinogenic risk and population density.